H.R.1076 — Preventing the Financing of Illegal Synthetic Drugs Act
House Roll Call
H.R.1076
| Bill | H.R.1076 — Preventing the Financing of Illegal Synthetic Drugs Act |
|---|---|
| Vote question | On Motion to Suspend the Rules and Pass, as Amended |
| Vote type | 2/3 Yea-And-Nay |
| Result | Passed |
| Totals | Yea 402 / Nay 2 / Present 0 / Not Voting 30 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 208 | 2 | 0 | 11 |
| D | 194 | 0 | 0 | 19 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Motion to Suspend the Rules and Pass, as Amended
Bill Analysis
The Preventing the Financing of Illegal Synthetic Drugs Act (HR 1076) aims to enhance the United States’ efforts to combat the trafficking and financing of illegal synthetic drugs, particularly fentanyl and its analogs. The bill was signed into law as Public Law No: 118-79 on October 6, 2023.
Key Provisions: The law establishes a framework for the identification and disruption of financial networks that facilitate the production and distribution of synthetic drugs. It mandates the Secretary of the Treasury to collaborate with federal, state, and local law enforcement agencies to improve the tracking of financial transactions linked to synthetic drug trafficking.
Funding and Authorities: The law authorizes the allocation of resources to the Financial Crimes Enforcement Network (FinCEN) to enhance its capabilities in monitoring and analyzing suspicious financial activities related to synthetic drugs. It also provides the Department of Justice (DOJ) with additional tools to prosecute individuals and organizations involved in the financing of synthetic drug trafficking.
Programs and Agencies Affected: Key agencies impacted by this legislation include FinCEN, the Drug Enforcement Administration (DEA), and the DOJ. The law encourages inter-agency cooperation and the sharing of intelligence to effectively target and dismantle synthetic drug trafficking operations.
Beneficiaries and Regulations: The primary beneficiaries of this law are communities affected by the opioid crisis, law enforcement agencies, and public health organizations. By disrupting the financial underpinnings of synthetic drug trafficking, the law aims to reduce the availability of these substances, ultimately protecting public health and safety.
Key Timelines: Following its enactment, the law requires the Secretary of the Treasury to report to Congress on the implementation of its provisions within one year. This report will detail the effectiveness of the measures taken and any recommendations for further actions to combat synthetic drug trafficking.
Yea (402)
C
Colin Allred
K
Kelly Armstrong
D
Dan Bishop
E
Earl Blumenauer
J
Jamaal Bowman
K
Ken Buck
L
Larry Bucshon
M
Michael Burgess
C
Cori Bush
K
Ken Calvert
Y
Yadira Caraveo
J
Jerry Carl
M
Matt Cartwright
L
Lori Chavez-DeRemer
D
David Cicilline
G
Gerald Connolly
J
Jason Crow
A
Anthony D'Esposito
L
Lloyd Doggett
J
John Duarte
J
Jeff Duncan
A
Anna Eshoo
A
A. Ferguson
S
Scott Franklin
M
Mike Gallagher
R
Ruben Gallego
M
Mike Garcia
B
Bob Good
K
Kay Granger
M
Mark Green
B
Brian Higgins
J
Jeff Jackson
S
Sheila Jackson Lee
B
Bill Johnson
D
Daniel Kildee
D
Derek Kilmer
A
Ann Kuster
D
Doug Lamborn
J
Jake LaTurner
B
Barbara Lee
D
Debbie Lesko
B
Blaine Luetkemeyer
K
Kathy Manning
L
Lucy McBath
L
Lisa McClain
M
Marcus Molinaro
A
Alexander Mooney
G
Grace Napolitano
W
Wiley Nickel
B
Bill Pascrell
D
Donald Payne
G
Greg Pence
D
Dean Phillips
K
Katie Porter
B
Bill Posey
C
Cathy Rodgers
M
Matthew Rosendale
C
C. Ruppersberger
J
John Rutherford
G
George Santos
J
John Sarbanes
D
David Schweikert
P
Pete Sessions
A
Abigail Spanberger
M
Michelle Steel
C
Chris Stewart
E
Eric Swalwell
R
Rashida Tlaib
D
David Trone
N
Nydia Velázquez
M
Michael Waltz
D
Debbie Wasserman Schultz
B
Brad Wenstrup
J
Jennifer Wexton
S
Susan Wild
B
Brandon Williams
Nay (2)
M
Matt Gaetz
Not Voting (30)
T
Tony Cárdenas
J
John Garamendi
G
Garret Graves
R
Raúl Grijalva
P
Patrick McHenry
M
Mary Peltola
